Peter Kasan

2.8k total citations
5 papers, 41 citations indexed

About

Peter Kasan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Peter Kasan has authored 5 papers receiving a total of 41 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in Peter Kasan's work include Lung Cancer Research Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Peter Kasan is often cited by papers focused on Lung Cancer Research Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Peter Kasan collaborates with scholars based in Slovakia, Czechia and Estonia. Peter Kasan's co-authors include Petr Zatloukal, Florence Lefresne, Mary O’Brien, Aleksandra Szczęsna, Wolfgang Hartmann, Tim Eisen, Dana Lucia Stănculeanu, Branko Zakotnik, Erik Biroš and Stephen Brincat and has published in prestigious journals such as Annals of Oncology, Journal of Thoracic Oncology and Lung Cancer.

In The Last Decade

Peter Kasan

3 papers receiving 38 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Kasan Slovakia	3	28	19	15	5	4	5	41
Sophia Schuman United States	2	18 0.6×	14 0.7×	21 1.4×	4 0.8×	2 0.5×	5	38
P. Kovoor United States	3	16 0.6×	19 1.0×	8 0.5×	8 1.6×	5 1.3×	5	43
Nathalie Prim France	5	19 0.7×	24 1.3×	10 0.7×	2 0.4×	2 0.5×	8	41
Hongbo Zheng China	5	31 1.1×	22 1.2×	11 0.7×	3 0.6×		13	63
Corinna Slawinski United Kingdom	2	29 1.0×	9 0.5×	10 0.7×	7 1.4×		4	45
Charlotte Fenioux France	4	18 0.6×	13 0.7×	9 0.6×	6 1.2×	5 1.3×	9	44
AnneMarie Culazzo Pferdekamper United States	2	17 0.6×	18 0.9×	12 0.8×		4 1.0×	4	23
Till Wallrabenstein Switzerland	3	29 1.0×	14 0.7×	7 0.5×	3 0.6×		4	36
Celin Tompkins United States	3	22 0.8×	17 0.9×	43 2.9×	4 0.8×	14 3.5×	3	65

Countries citing papers authored by Peter Kasan

Since Specialization

Citations

This map shows the geographic impact of Peter Kasan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kasan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kasan more than expected).

Fields of papers citing papers by Peter Kasan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kasan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kasan. The network helps show where Peter Kasan may publish in the future.

Co-authorship network of co-authors of Peter Kasan

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kasan. A scholar is included among the top collaborators of Peter Kasan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kasan. Peter Kasan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Kasan, Peter, et al.. (2019). EP1.14-34 Advanced NSCLC Treated with Gefitinib or Erlotinib for Five Years or Longer - Updated Data from the Retrospective Slovakian Study. Journal of Thoracic Oncology. 14(10). S1045–S1045.

2.

Kasan, Peter, et al.. (2018). P3.13-11 Advanced NSCLC Treated with Gefitinib or Erlotinib for Five Years or Longer - Retrospective Slovakian Study. Journal of Thoracic Oncology. 13(10). S980–S980.

3.

Pirker, Robert, Stephen Brincat, Peter Kasan, et al.. (2010). Therapy of small cell lung cancer with emphasis on oral topotecan. Lung Cancer. 70(1). 7–13. 12 indexed citations

4.

O’Brien, Mary, Aleksandra Szczęsna, Petr Zatloukal, et al.. (2004). Vinorelbine alternating oral and intravenous plus carboplatinin advanced non-small-cell lung cancer: results of a multicentre phase II study. Annals of Oncology. 15(6). 921–927. 17 indexed citations

5.

Böör, A, et al.. (2004). Expression of the multidrug resistance-associated protein 1 (MRP1) and the lung resistance-related protein (LRP) in human lung cancer.. PubMed. 51(3). 169–74. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact